Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$5.92 USD
+0.27 (4.78%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $5.92 0.00 (0.00%) 6:40 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.54 | 0.00% |
Earnings Summary
For their last quarter, Verrica Pharmaceuticals (VRCA) reported earnings of -$0.48 per share, missing the Zacks Consensus Estimate of -$0.47 per share. This reflects a negative earnings surprise of 2.13%. Look out for VRCA's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.54 per share, reflecting a year-over-year decrease of 315.38%.
Earnings History
Price & Consensus
Zacks News for VRCA
Best Momentum Stocks to Buy for April 18th
VRCA: What are Zacks experts saying now?
Zacks Private Portfolio Services